This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Abbvie Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Work of Roberto M Risi in Cancer Research
Introduction: Roberto M Risi is an accomplished inventor based in Kenosha, Wisconsin. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of treatments for serious diseases such as cancer. With a focus on innovative solutions, Risi’s work exemplifies the pivotal role inventors play in advancing medical science.
Latest Patents: Risi holds a patent for "Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors." This patent discloses compounds of Formula (IIa), which are designed to function as agents in treating diseases, including various forms of cancer. These compounds also include their pharmaceutically acceptable salts, highlighting Risi's innovative approach to drug development. Moreover, the patent encompasses pharmaceutical compositions that utilize one or more of these compounds, showcasing the tangible impact of his work in the industry.
Career Highlights: Risi is a key researcher at AbbVie Inc., a global biopharmaceutical company known for its innovation in drug development. His work within this esteemed organization has positioned him at the forefront of pharmaceutical research. With a dedicated focus on oncology, Risi's contributions have influenced ongoing research and the development of new therapeutic options for patients.
Collaborations: Throughout his career, Risi has collaborated with talented colleagues, including Yunsong Tong and Milan Bruncko. These partnerships are vital in the collaborative environment of pharmaceutical research, enhancing the creative process and leading to groundbreaking discoveries in the field.
Conclusion: Roberto M Risi is a notable inventor whose work in developing CDK9 kinase inhibitors has the potential to provide new avenues for cancer treatment. His affiliation with AbbVie Inc. and collaborations with other skilled researchers highlight the importance of teamwork and innovation in the pharmaceutical industry. As scientists continue their quest to improve human health, Risi's contributions remain a beacon of progress in the fight against cancer.